These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 26531778

  • 1. Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.
    Zheng J, Dai Y, Yang Z, Yang L, Peng Z, Meng R, Xiong Y, He J.
    Oncol Rep; 2016 Jan; 35(1):530-7. PubMed ID: 26531778
    [Abstract] [Full Text] [Related]

  • 2. EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients.
    Peng Z, Wang Q, Zhang Y, He J, Zheng J.
    Int J Oncol; 2016 Oct; 49(4):1737-45. PubMed ID: 27509846
    [Abstract] [Full Text] [Related]

  • 3. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
    Yao W, Feng D, Bian W, Yang L, Li Y, Yang Z, Xiong Y, Zheng J, Zhai R, He J.
    Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
    [Abstract] [Full Text] [Related]

  • 4. Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells.
    Clapéron A, Guedj N, Mergey M, Vignjevic D, Desbois-Mouthon C, Boissan M, Saubaméa B, Paradis V, Housset C, Fouassier L.
    Oncogene; 2012 Mar 15; 31(11):1376-88. PubMed ID: 21822312
    [Abstract] [Full Text] [Related]

  • 5. EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.
    Li H, Zhang B, Liu Y, Yin C.
    Med Oncol; 2014 Sep 15; 31(9):162. PubMed ID: 25119502
    [Abstract] [Full Text] [Related]

  • 6. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S, Li Y, Yang Y, Feng D, Yang L, Ma Q, Zheng S, Meng R, Wang S, Wang S, Jiang WG, He J.
    FEBS Lett; 2013 Oct 11; 587(20):3289-95. PubMed ID: 24012959
    [Abstract] [Full Text] [Related]

  • 7. The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.
    Shao G, Wang R, Sun A, Wei J, Peng K, Dai Q, Yang W, Lin Q.
    Mol Cancer; 2018 Feb 19; 17(1):24. PubMed ID: 29455656
    [Abstract] [Full Text] [Related]

  • 8. Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt.
    Yamasaki F, Johansen MJ, Zhang D, Krishnamurthy S, Felix E, Bartholomeusz C, Aguilar RJ, Kurisu K, Mills GB, Hortobagyi GN, Ueno NT.
    Cancer Res; 2007 Jun 15; 67(12):5779-88. PubMed ID: 17575145
    [Abstract] [Full Text] [Related]

  • 9. Phosphatase and tensin homolog regulates stability and activity of EphB1 receptor.
    Rodriguez S, Huynh-Do U.
    FASEB J; 2013 Feb 15; 27(2):632-44. PubMed ID: 23118026
    [Abstract] [Full Text] [Related]

  • 10. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
    Festuccia C, Muzi P, Millimaggi D, Biordi L, Gravina GL, Speca S, Angelucci A, Dolo V, Vicentini C, Bologna M.
    Endocr Relat Cancer; 2005 Dec 15; 12(4):983-98. PubMed ID: 16322337
    [Abstract] [Full Text] [Related]

  • 11. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
    DU G, Hao C, Gu Y, Wang Z, Jiang WG, He J, Cheng S.
    Anticancer Res; 2016 Mar 15; 36(3):1165-73. PubMed ID: 26977012
    [Abstract] [Full Text] [Related]

  • 12. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A, Ehrmann J, Sedlakova E, Krejci V, Knizetova P, Fiuraskova M, Kala M, Kalita O, Kolar Z.
    Neoplasma; 2007 Mar 15; 54(4):334-41. PubMed ID: 17822324
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, Bologna M.
    Thromb Haemost; 2005 May 15; 93(5):964-75. PubMed ID: 15886816
    [Abstract] [Full Text] [Related]

  • 14. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
    Song J, Bai J, Yang W, Gabrielson EW, Chan DW, Zhang Z.
    Histopathology; 2007 Jul 15; 51(1):40-53. PubMed ID: 17593079
    [Abstract] [Full Text] [Related]

  • 15. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y.
    Oncogene; 2010 Sep 02; 29(35):4947-58. PubMed ID: 20562913
    [Abstract] [Full Text] [Related]

  • 16. Protein phosphatase 2A PR130/B''alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling.
    Zwaenepoel K, Goris J, Erneux C, Parker PJ, Janssens V.
    FASEB J; 2010 Feb 02; 24(2):538-47. PubMed ID: 19825976
    [Abstract] [Full Text] [Related]

  • 17. Ezrin-Radixin-Moesin Binding Phosphoprotein 50 (EBP50) Suppresses the Metastasis of Breast Cancer and HeLa Cells by Inhibiting Matrix Metalloproteinase-2 Activity.
    Wang L, Qi Y, Xiong Y, Peng Z, Ma Q, Zhang Y, Song J, Zheng J.
    Anticancer Res; 2017 Aug 02; 37(8):4353-4360. PubMed ID: 28739728
    [Abstract] [Full Text] [Related]

  • 18. PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells.
    Tang LL, Yokoyama Y, Wan X, Iwagaki S, Niwa K, Tamaya T.
    Oncol Rep; 2006 Apr 02; 15(4):855-9. PubMed ID: 16525671
    [Abstract] [Full Text] [Related]

  • 19. P53 and PTEN expression contribute to the inhibition of EGFR downstream signaling pathway by cetuximab.
    Bouali S, Chrétien AS, Ramacci C, Rouyer M, Marchal S, Galenne T, Juin P, Becuwe P, Merlin JL.
    Cancer Gene Ther; 2009 Jun 02; 16(6):498-507. PubMed ID: 19165235
    [Abstract] [Full Text] [Related]

  • 20. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
    Nishimura Y, Takiguchi S, Ito S, Itoh K.
    Int J Oncol; 2015 Apr 02; 46(4):1721-9. PubMed ID: 25653196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.